The Trump administration has selected five companies, including Moderna Inc, AstraZeneca Plc and Pfizer Inc, as the most likely candidates to produce a vaccine for the novel coronavirus, the New York Times reported on Wednesday, citing senior officials.
The other companies are Johnson & Johnson and Merck & Co Inc, according to the newspaper.
The selected companies will get access to additional government funds, help in running clinical trials, and financial and logistical support, the paper reported.
There is no approved vaccine for COVID-19, the respiratory disease caused by the new coronavirus.
No comments
Post a Comment